GE HealthCare Technologies
GE HealthCare Technologies returns on capital
Annual and trailing 12-month returns on invested capital, equity and assets.
ROIC
% · Annual / TTM
ROCE
% · Annual / TTM
ROIIC
% · Annual / TTM
ROE
% · Annual / TTM
ROA
% · Annual / TTM
ROIC − WACC
Percentage points · Scenario
Quarterly data
| Fiscal period | Ended | ROIC% | ROCE% | ROIIC% | ROE% | ROA% | ROIC − WACCPercentage points |
|---|---|---|---|---|---|---|---|
| FY 2026 Q2 | Jun 30, 2026 | 11.3% | 10% | -24.44% | 19.19% | 5.46% | 3.6 pp |
| FY 2026 Q1 | Mar 31, 2026 | 11.25% | 10.15% | -17.6% | 19.24% | 5.4% | 3.5 pp |
| FY 2025 Q4 | Dec 31, 2025 | 13.25% | 10.76% | 18% | 22.14% | 5.95% | 5.6 pp |
| FY 2025 Q3 | Sep 30, 2025 | 13.1% | 10.68% | 18.67% | 24.22% | 6.34% | 5.4 pp |
| FY 2025 Q2 | Jun 30, 2025 | 13.31% | 11.2% | 26.13% | 25.59% | 6.65% | 5.6 pp |
| FY 2025 Q1 | Mar 31, 2025 | 13.55% | 11.56% | 22.12% | 26.31% | 6.64% | 5.9 pp |
| FY 2024 Q4 | Dec 31, 2024 | 13.39% | 11.17% | 44% | 25.59% | 6.08% | 5.7 pp |
| FY 2024 Q3 | Sep 30, 2024 | 11.85% | 10.05% | — | 21.69% | 5.06% | 4.2 pp |
| FY 2024 Q2 | Jun 30, 2024 | 10.85% | 10.17% | — | 21.2% | 4.92% | 3.1 pp |
| FY 2024 Q1 | Mar 31, 2024 | 11.33% | 10.12% | — | 22.27% | 4.84% | 3.6 pp |
| FY 2023 Q4 | Dec 31, 2023 | — | — | — | — | — | — |
| FY 2023 Q3 | Sep 30, 2023 | — | — | — | — | — | — |
| FY 2023 Q2 | Jun 30, 2023 | — | — | — | — | — | — |
| FY 2023 Q1 | Mar 31, 2023 | — | — | — | — | — | — |
Sources and calculations
Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.
Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.
Quarterly returns use trailing 12-month earnings and period-end balances averaged with the same fiscal quarter one year earlier. NOPAT uses the reported effective tax rate only when pretax profit is positive and the rate is between 0 and 100%. WACC starts at 7.7%, rounded from the US nonfinancial market · generic proxy benchmark in NYU Stern · January 2026. It is an editable US sector proxy applied across history, not a company estimate; foreign reporting currencies also need a currency-specific assessment.
Market prices: Yahoo Finance · GEHC, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.
- ROIC
- NOPAT / average invested capital × 100. NOPAT = operating income × (1 − effective tax rate). Invested capital = equity including noncontrolling interests + debt − cash and equivalents. Average uses period end and one year earlier.
- ROCE
- Operating income / average (assets − current liabilities) × 100, using period end and one year earlier.
- ROIIC
- Year-over-year change in annual/TTM NOPAT / positive year-over-year change in invested capital × 100. Capital reductions and missing inputs yield unavailable values.
- ROE
- Earnings attributable to owners / average equity attributable to owners × 100, using period end and one year earlier.
- ROA
- Net income / average total assets × 100, using period end and one year earlier.
- ROIC − WACC
- ROIC less your WACC assumption, in percentage points. The same scenario rate is applied across history; it is not a reported or historical company WACC.